Immunotherapy Today

Immunotherapy News From Around The World

FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times

Posted by btwatson on March 9, 2019 5:49 pm
Tags:
Categories: Crispr Articles

Source: FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times

[unable to retrieve full-text content]

  1. FDA OKs First Immunotherapy Combo Regimen for Breast Cancer  Pharmacy Times
  2. Roche wins first US approval of immunotherapy for breast cancer  STAT
  3. FDA approves 1st immunotherapy drug to treat breast cancer  ABC News
  4. FDA approves first immunotherapy regimen for breast cancer  CNN
  5. Roche wins first immunotherapy approval for triple-negative breast cancer  BioPharma Dive
  6. View full coverage on Google News

Published at Fri, 08 Mar 2019 21:30:59 +0000

< Immunotherapy Today home

Immunotherapy News

  • Smoldering multiple myeloma in transition: redefining early myeloma in the modern era - Nature
    May 5, 2026
  • Incorporating Immunotherapy into Upfront Acute Lymphoblastic Leukemia Therapy - Resonance - Oncodaily
    May 5, 2026
  • Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions - Nature
    May 5, 2026
  • Improving How Multiple Myeloma Is Understood and Treated | Newswise - Newswise
    May 4, 2026
  • Gut microbiome may help predict melanoma recurrence after immunotherapy - Managed Healthcare Executive
    May 4, 2026
  • Defining Maintenance Therapy and Unmet Needs in ES-SCLC - Targeted Oncology
    May 4, 2026
  • Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy - Fox News
    May 4, 2026
  • Supporting the Next Generation of Cancer Immunotherapy Experts – SITC - Oncodaily
    May 4, 2026
  • Exploring the Potential of Ozekibart in Relapsed Ewing Sarcoma - Targeted Oncology
    May 4, 2026
  • Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy - Oncodaily
    May 4, 2026

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com